Rubina Parmar

Rubina Parmar currently serves as the Vice President of Chemistry & Delivery Sciences at Intellia Therapeutics, Inc., a position held since September 2017. Previously, Rubina held the role of Lead Scientist/Associate Director at Alnylam Pharmaceuticals from February 2014 to August 2017, focusing on the design and synthesis of novel nucleotide chemistries. Prior to that, Rubina worked at Merck & Co., Inc. as an Associate Principal Scientist from December 2006 to January 2014, where significant contributions included the development of lipid nanoparticles and polymer conjugates for siRNA delivery, resulting in multiple patent applications. Earlier experiences include positions at Sirna Therapeutics and Sigma Proligo, where Rubina specialized in the synthesis of lipids and amidites for oligonucleotide synthesis. Rubina holds a Ph.D. in Organic Chemistry from Punjabi University.